A single company can only do so much. Just as a single country cannot keep out multiple drug-resistant bacteria. In the fight against AMR, we have therefore taken on a high-profile campaigning role. We do this by calling on both the industry and the entire value chain to act responsibly and stop buying, using or selling irresponsibly made antibiotics. We aim to create awareness that industrial antibiotics pollution significantly contributes to antimicrobial resistance and that sustainable and responsible production of antibiotics is not only imperative, but also economically feasible.
This was acknowledged with the publication of the Review on AMR report, issued by the UK government, in May 2016.
Key Industry initiatives
A number of key initiatives within the industry have been deployed to actively battle the rise of AMR.
In 2016 we received the prestigious Cefic European Responsible Care Award in the Product Stewardship Category, for our work on Sustainable Antibiotics. Cefic (the European Chemical Industry Council) runs the award as part of its efforts to strengthen the Responsible Care initiative, the global industry’s commitment to sustainability, and to encourage the use of best practices across Europe.
Read more about our memberships here.